Morgan Stanley Cozies Up to Medical Marijuana Stock GWPH

Now watching

Next video starts in : 7 Play

Morgan Stanley Cozies Up to Medical Marijuana Stock GWPH

Morgan Stanley Cozies Up to Medical Marijuana Stock GWPH
Replay video
Up next

Will oil deja vu tank prices in 2016?

Unlock your personal NFL Now stream by signing in to NFL.com

Morgan Stanley Cozies Up to Medical Marijuana Stock GWPH

by TheStreet.com Videos 1:10 mins

Morgan Stanley has given GW Pharmaceuticals (GWPH) its vote of confidence, stamping the leader in cannabis-based drugs with a bullish "overweight" rating and a $103.00 price target for the stock on account of the upside potential of epilepsy drug Epidiolex and the company's "novel platform." Upon the pre-market release of the bank's upgrade, the stock jumped from its Monday close of $46.04 to an opening price of $50.10. And the stock continued to roar throughout the trading day Tuesday.

View Comments (0)